 |
|
Joslin-led study uncovers role of appetite hormone MCH in insulin production
January 29, 2007A new Joslin Diabetes Center-led study has shown conclusively that a neuropeptide, melanin concentrating hormone (MCH), found in the brain and known for its role in increasing appetite in people, plays a role in the growth of insulin-producing beta cells and the secretion of insulin. This finding has the potential to spur the development of new treatments for diabetes that stimulate the production of insulin-producing beta cells in the pancreas. This latest research, conducted with researchers at Beth Israel Deaconess Medical Center in Boston and other institutions, will appear in the February 2007 issue of Diabetes.
An earlier Joslin-led study examined the connection between obesity and MCH, which plays a critical role in energy balance and appetite, observing an increase in the number of beta cells when MCH levels are high. This was a new finding that had not been observed before. Although MCH's role in appetite control is well known, its effects on the secretion of endocrine hormones has not been fully understood.
"It's a very logical connection," says Rohit N. Kulkarni, M.D., Ph.D., investigator at Joslin Diabetes Center and Assistant Professor of Medicine at Harvard Medical School, who led the study. "Whenever you eat food, your body needs more insulin. When MCH induces appetite, it simultaneously increases insulin secretion from beta cells and enhances growth of beta cells. If the proteins that mediate the growth mechanism can be identified, it could lead to the development of new drugs that would enhance beta cell growth to treat type 1 and type 2 diabetes."
In type 1 diabetes (insulin-dependent) diabetes, which accounts for 5 to 10 percent (between 700,000 and 1.4 million people) of diabetes cases in the United States, an autoimmune process has destroyed the insulin-producing islet cells in the pancreas. In type 2 diabetes, the far more common form of the disease, the body doesn't produce enough insulin and/or can't use insulin properly (insulin resistance). Both diseases could benefit from treatments that stimulate beta cells in the pancreas to produce insulin.
In the first study, in which mice were genetically engineered to over-express MCH, Dr. Kulkarni and his colleagues observed changes in beta cell mass out of proportion with the degree of obesity, suggesting that MCH had a direct effect on islets. To build on these previous findings, the researchers focused this study on gaining a deeper understanding of how MCH and its receptors influence growth of beta cells.
The investigators first confirmed that MCH and its receptors are indeed expressed in islet cells of mice and humans. They then treated human donor or mouse pancreatic islet cells with MCH and found that it increased insulin secretion, compared to islet cells without MCH, which did not show the same effect.
In the next phase, the researchers examined genetically-engineered mice that did not produce MCH and consequently had abnormally small islets. "This indicated to us that MCH is important for growth of islets," says Dr. Kulkarni.
The next step in the research process is to pinpoint exactly how MCH is regulating the growth of beta cells and identify which proteins are involved in this growth process. "We know MCH is having an effect on both growth and function likely by recruiting different proteins. It will be worth exploring which proteins are being activated by MCH to cause the growth effect," Dr. Kulkarni explains.
A follow-up study has been designed and is currently awaiting funding. It will look at how MCH interacts with glucagon-like peptide 1 (GLP-1), a hormone involved in beta cell growth. An analogue of GLP-1 hormone has already been approved by the FDA for treating type 2 diabetes. The goal is to understand how GLP-1 and MCH can work together to promote beta cell growth.
Joslin Diabetes Center
In type 1 diabetes (insulin-dependent) diabetes, which accounts for 5 to 10 percent (between 700,000 and 1.4 million people) of diabetes cases in the United States, an autoimmune process has destroyed the insulin-producing islet cells in the pancreas. In type 2 diabetes, the far more common form of the disease, the body doesn't produce enough insulin and/or can't use insulin properly (insulin resistance). Both diseases could benefit from treatments that stimulate beta cells in the pancreas to produce insulin.
In the first study, in which mice were genetically engineered to over-express MCH, Dr. Kulkarni and his colleagues observed changes in beta cell mass out of proportion with the degree of obesity, suggesting that MCH had a direct effect on islets. To build on these previous findings, the researchers focused this study on gaining a deeper understanding of how MCH and its receptors influence growth of beta cells.
The investigators first confirmed that MCH and its receptors are indeed expressed in islet cells of mice and humans. They then treated human donor or mouse pancreatic islet cells with MCH and found that it increased insulin secretion, compared to islet cells without MCH, which did not show the same effect.
In the next phase, the researchers examined genetically-engineered mice that did not produce MCH and consequently had abnormally small islets. "This indicated to us that MCH is important for growth of islets," says Dr. Kulkarni.
The next step in the research process is to pinpoint exactly how MCH is regulating the growth of beta cells and identify which proteins are involved in this growth process. "We know MCH is having an effect on both growth and function likely by recruiting different proteins. It will be worth exploring which proteins are being activated by MCH to cause the growth effect," Dr. Kulkarni explains.
A follow-up study has been designed and is currently awaiting funding. It will look at how MCH interacts with glucagon-like peptide 1 (GLP-1), a hormone involved in beta cell growth. An analogue of GLP-1 hormone has already been approved by the FDA for treating type 2 diabetes. The goal is to understand how GLP-1 and MCH can work together to promote beta cell growth.
Joslin Diabetes Center
Insulin Current Events and Insulin News RSSHuman genomics in China
Ten years ago, the Chinese National Human Genome Center at Shanghai (South Center, hereafter) was established in the Zhangjiang HiTech Park of Pudong District in Shanghai. To commemorate this important event, which marks the beginning of the Genomics Era in China, we specially organize a series of mini-reviews for this special issue.
Hormone therapy associated with reduced colorectal cancer risk
The combination of estrogen plus progestin, which women stopped taking in droves following the news that it may increase their risk of breast cancer, may decrease their risk of colorectal cancer, according to a report published in the January issue of Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.
Obesity: Reviving the promise of leptin
The discovery more than a decade ago of leptin, an appetite-suppressing hormone secreted by fat tissue, generated headlines and great hopes for an effective treatment for obesity.
Researchers engineer pancreatic cell transplants to evade immune response
In a finding that could significantly influence the way type 1 diabetes is treated, researchers at Albert Einstein College of Medicine of Yeshiva University have developed a technique for transplanting insulin-producing pancreatic cells that causes only a minimal immune response in recipients.
Researchers at Columbia University Medical Center link blood sugar to normal cognitive aging
Maintaining blood sugar levels, even in the absence of disease, may be an important strategy for preserving cognitive health, suggests a study published by researchers at Columbia University Medical Center (CUMC). The study appeared in the December issue of Annals of Neurology.
Another reason to avoid high-fat diet -- it can disrupt our biological clock
Indulgence in a high-fat diet can not only lead to overweight because of excessive calorie intake, but also can affect the balance of circadian rhythms - everyone's 24-hour biological clock, Hebrew University of Jerusalem researchers have shown.
Leptin's long-distance call to the pancreas
Rube Goldberg-the cartoonist who devised complex machines for simple tasks-would have smiled at one of leptin's mechanisms for curbing insulin release.
New scientific knowledge on juvenile diabetes
Finnish scientists have reported a breakthrough in the attempts to understand the development of type 1 diabetes. They discovered disturbances in lipid and amino acid metabolism in children who later progressed to type 1 diabetes, also known as juvenile diabetes.
Prevalence of disordered eating behaviors in diabetics probed
Children with diabetes are at an increased risk for developing eating disorders and researchers want to know if it's their disease or treatment that's to blame.
U of I study: Fructose metabolism more complicated than was thought
A new University of Illinois study suggests that we may pay a price for ingesting too much fructose. According to lead author Manabu Nakamura, dietary fructose affects a wide range of genes in the liver that had not previously been identified.
More Insulin Current Events and Insulin News Articles
 | The Insulin-Resistance Diet--Revised and Updated: How to Turn Off Your Body's Fat-Making Machine by Cheryle Hart, Mary Kay Grossman Conquer insulin resistance. Reduce cravings. Eat your favorite foods. And lose weight!. If you have tried every diet and are still struggling with your weight, the real culprit may be insulin resistance. When you have more glucose than your body needs, your body responds by producing more insulin to stabilize your blood sugar level and store the excess glucose as fat. In The Insulin-Resistance... |
 | Pumping Insulin: Everything You Need For Success On A Smart Insulin Pump by John Walsh, Ruth Roberts |
 | The Discovery of Insulin: Twenty-fifth Anniversary Edition by Michael Bliss When insulin was discovered in the early 1920s, even jaded professionals marveled at how it brought starved, sometimes comatose diabetics back to life. In this now-classic study, Michael Bliss unearths a wealth of material, ranging from scientists’ unpublished memoirs to the confidential appraisals of insulin by members of the Nobel Committee. He also resolves a longstanding controversy dating... |
 | Using Insulin, Everything You Need for Success With Insulin by John Walsh, Ruth Roberts, Timothy Bailey, Chandra B. Varma |
 | Insulin Pump Therapy Demystified: An Essential Guide for Everyone Pumping Insulin (Marlowe Diabetes Library) by Gabrielle Kaplan-Mayer Increasing numbers of people with type 1 diabetes, all of whose lives depend on insulin, as well as type 2 diabetics, have already adopted the insulin pump, which replaces a regimen of insulin shots with a continuous delivery of insulin. Yet many who stand to benefit from "the pump" are put off by not fully understanding the device, and many already using it don’t have anyone with whom to... |
 | Syndrome X: The Complete Nutritional Program to Prevent and Reverse Insulin Resistance by Jack Challem, Burton Berkson, Melissa Diane Smith You can feel great again! "Syndrome X proactively lays out a nutritious, tasty, and simple diet plan to get us back to the basics of healthy nutrition."–Lendon H. Smith, M.D., New York Times bestselling author of Feed Your Body Right "Syndrome X is the best new book to help you understand the facts about nutrition, health, and aging. . . . It is full of new information and insights... |
 | Blood Sugar Blues : Overcoming the Hidden Dangers of Insulin Resistance by Miryam Ehrlich Williamson, R. Paul St. Amand M.D. A vitally important new book about a widespread condition we’re just beginning to understandAn estimated 20 percent of Americans (55 million people) are insulin resistant—and most of them don't know it! Their high carbohydrate intake is causing their bodies to become immune to their own insulin, and the resulting high blood sugar levels are increasingly linked to diseases and disorders, from... |
 | Pumping Insulin: Everything You Need for Success With an Insulin Pump by John Walsh, Ruth Roberts |
 | Practical Insulin (American Diabetes Association) by American Diabetes Association Reliable information in a handy pocket reference Practical Insulin is a revised version of a popular bestseller.Now, with information on the newly FDA-approved insulins, such as inhaled, this handy reference gives you fast, reliable information to overcome the challenges you face in choosing a regime to effectively manage insulin resistance. It includes data on all types of insulin, mixing... |
 | The Glycemic-Load Diet: A powerful new program for losing weight and reversing insulin resistance by Rob Thompson A cardiologist's revolutionary weight-loss plan that allows dieters to enjoy good carbs while still losing weight. . The glycemic index has been the basis of many popular diets. But it doesn't take into account the serving sizes people actually eat and eliminates too many foods for dieters to stick with it. Now Dr. Robert Thompson's breakthrough program uses the glycemic load--the glycemic... |
| © 2009 BrightSurf.com |